SCHEMBL30108075

SCHEMBL30108075

c1coc(-c2cc(-n3nnc4ccc(OCCC5CCNCC5)cc43)ncn2)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CHEK2 O96017 1/20 0.34
ITGB3 P05106 4/20 0.33
ITGA2B P08514 4/20 0.33
PIM1 P11309 4/20 0.33
KCNH2 Q12809 3/20 0.33
FLT3 P36888 2/20 0.33
PIM3 Q86V86 2/20 0.33
PIM2 Q9P1W9 2/20 0.33
KHK P50053 1/20 0.32
AKT1 P31749 1/20 0.32
CTSS P25774 1/20 0.32
ADORA3 P0DMS8 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA2B P29275 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30108021 0.88 KDM4E (0.36) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30107960 0.84 SLC6A2 (0.40) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108077 0.72 SLC6A2 (0.40) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30107972 0.68 KDM4E (0.35) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108071 0.66 KDM4E (0.39) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30108011 0.65 TLR9 (0.43) KDM4EALDH1A1GAATSHR
SCHEMBL30108016 0.62 CHEK2 (0.47) HPGDCHEK2ITGB3ITGA2BKCNH2
SCHEMBL30107937 0.61 HSD17B10 (0.38) KDM4EALDH1A1GAAHPGDTSHR
SCHEMBL30186215 0.61 SLC6A2 (0.73) KDM4ECHEK2ITGB3ITGA2BKCNH2
SCHEMBL4329812 0.59 ITGB3 (0.49) CHEK2ITGB3ITGA2BADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed